Rexielyn Diaz
- Indexed articles, last 90 days
- 6
- Latest publication
- Sep 16, 2026
- Outlet visibility, for yahoo.com
- Top 1K sites
- Earliest in this view
- Sep 16, 2026
Latest articles
Starbucks Is Weighing a Japan Stake Sale. Here’s What It Means for the Turnaround (opens the original)
Read excerpt
Starbucks (SBUX) is exploring the sale of a majority stake in its Japan business, Reuters reported this week. The deal could value the unit at roughly $3 billion. Shares have held mostly flat over the past week near $97, but the news adds another chapter to a portfolio overhaul that has defined 2026. Japan is Starbucks' largest company-operated market outside the U.S., with 1,883 stores accounting for nearly 9% of its global footprint. Starbucks acquired the business outright from local partner
Lumentum Stock Is Up Nearly 10% This Week. Here’s the Case for 27.5% Annual Returns (opens the original)
Read excerpt
Lumentum (LITE) jumped roughly 10% this week as chip stocks broadly rallied on bullish sector commentary from Citi. Rival optics supplier IQE's earnings reinforced the same message investors have heard all year, since AI data center demand for optical parts keeps exceeding supply. Shares now trade near $919, well above their 52-week low of $145. The rally builds on an already strong quarter. Lumentum's Q4 fiscal 2026 results, reported in mid-August, showed revenue more than doubling to $1.01 bil
DoorDash Stock Trades 31% Below Its High. Here’s What Investors Are Watching (opens the original)
Read excerpt
Past two weeks performance: Consolidating DoorDash (DASH) has barely moved over the past two weeks. Shares sit near $197, about 31% below the 52-week high of $286. But the business itself has kept accelerating. Q2 results in early August showed why. Revenue rose about 36% year over year to roughly $4.45 billion, and adjusted EBITDA jumped 40% to $914 million, a 20.5% margin. Organic order value grew 23%, and management reaffirmed full-year EPS guidance near $2.54 on about $17.9 billion of revenu
Pfizer Raises 2026 Revenue Guidance to $62 Billion. Here’s What’s Behind the Beat (opens the original)
Read excerpt
Pfizer (PFE) barely moved this week. That quiet is the real story. Shares sit near $28, only a hair off where they started, even though the company just delivered one of its stronger quarters in years. Pfizer beat Q2 estimates with adjusted earnings per share of $0.77 and raised its full-year revenue guidance to $60.5 billion to $62.5 billion. Non-COVID products, the part of the business investors actually care about now, grew 18% operationally. The market's muted reaction says something importa
American Express Stock Is Up This Week. Here’s Why the Platinum Refresh Keeps Paying Off (opens the original)
Read excerpt
American Express (AXP) edged higher this week after the company reaffirmed its confidence at the Barclays Global Financial Services Conference. Management pointed to first-half 2026 revenue growth of 10% on an FX-adjusted basis. That performance pushed leadership to lift its full-year revenue outlook to roughly 10%, while keeping earnings-per-share guidance at $17.30 to $17.90. Investors have grown used to AmEx delivering, but the tone this week leaned more confident than cautious. The Platinum
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1K sites
For yahoo.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.